The Chemours Company
CC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $5,782 | $6,078 | $6,831 | $6,345 |
| % Growth | -4.9% | -11% | 7.7% | – |
| Cost of Goods Sold | $4,631 | $4,772 | $5,215 | $4,964 |
| Gross Profit | $1,151 | $1,306 | $1,616 | $1,381 |
| % Margin | 19.9% | 21.5% | 23.7% | 21.8% |
| R&D Expenses | $109 | $108 | $118 | $107 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $585 | $1,290 | $710 | $592 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $14 | $31 | $2 | $8 |
| Operating Expenses | $708 | $1,429 | $830 | $707 |
| Operating Income | $443 | -$123 | $786 | $674 |
| % Margin | 7.7% | -2% | 11.5% | 10.6% |
| Other Income/Exp. Net | -$316 | -$195 | -$45 | $2 |
| Pre-Tax Income | $127 | -$318 | $741 | $676 |
| Tax Expense | $41 | -$81 | $163 | $68 |
| Net Income | $86 | -$238 | $578 | $608 |
| % Margin | 1.5% | -3.9% | 8.5% | 9.6% |
| EPS | 0.58 | -1.6 | 3.72 | 3.69 |
| % Growth | 136.3% | -143% | 0.8% | – |
| EPS Diluted | 0.57 | -1.6 | 3.65 | 3.6 |
| Weighted Avg Shares Out | 149 | 149 | 155 | 165 |
| Weighted Avg Shares Out Dil | 150 | 149 | 158 | 169 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $264 | $208 | $163 | $185 |
| Depreciation & Amortization | $301 | $307 | $291 | $317 |
| EBITDA | $692 | $197 | $1,195 | $1,178 |
| % Margin | 12% | 3.2% | 17.5% | 18.6% |